Georg Behrens, MD, PhD

Behrens, Georg 2016_120Prof. Georg MN Behrens is Professor for T Cell Immunology in the Department for Clinical Immunology and Rheumatology and Head of the DFG-funded Clinical Research Group KFO 250 at Hannover Medical School, Hannover Germany. Born in 1968, Georg Behrens studied medicine at Hannover Medical School and Justus-Liebig-University Giessen. He graduated in Medicine at Hannover Medical School in 1995. In 1996 he finished his doctoral thesis in the Department of Clinical Immunology and Transfusion Medicine, Giessen. After this, he did his clinical training in Internal Medicine in Hannover. From 2001-2003, he went as a postdoc to the Immunology Division at the Walter and Eliza Hall Institute for Medical Research, Melbourne, Australia and returned to Hannover to become a professor for immunology and to build up a research group.

Georg Behrens is an internationally acknowledged expert on HIV-therapy and related metabolic side effects and has received several awards for his research in this area. In addition, his lab works on antigen presentation by dendritic cells (e.g. cross-presentation), anti-viral immunity and autoimmunity in transgenic mouse models. He has published numerous papers in journals such as Lancet, J Exp Med, J Clin Invest, Nat Immunol, AIDS, J Immunol and others. His laboratory is supported by the German Research Foundation (KFO 250, SFB 900, SFB 578), the Federal Ministry of Education and Research and others. He is principal investigator of national and international studies in HIV medicine and member of European Collaborations such as NEAT and HIVERA Network.

 He is president of the German AIDS Society, a Co-chair of the panel for the European Guidelines on prevention and management of non-infectious co-morbidities in HIV, a member of the Excellence Cluster »REBIRTH - From Regenerative Biology to Reconstructive Therapy«, and a faculty member of the Hannover Biomedical Research School (HBRS). He is reviewer for international journals in immunology and infectious diseases and is in the Editorial Boards of AIDS, Antiviral Therapy, HIV Medicine and Experimental Biology and Medicine.